M&A

News

Novo Nordisk in talks to buy device maker Biocorp

Danish pharma group Novo Nordisk has revealed it is in exclusive negotiations that could result in the acquisition of a controlling stake in Biocorp, a French company that

News

Flurry of deals in biotech as M&A activity picks up

After a slow couple of years, there are signs that biotech M&A activity is coming back into vogue, and a series of small transactions announced in the last few days pr

News

Lonza builds its ADC capacity with Synaffix takeover

Lonza has boosted its ability to cater for customers in the fast-emerging antibody-drug conjugate category with a deal to buy Dutch company Synaffix and its platform techn

News

Icahn pick displaces chair John Thompson on Illumina board

Illumina shareholders have voted to oust the company’s chairman John Thompson, although chief executive Francis DeSouza has emerged from the annual meeting unscathed.

News

Bankruptcy court clears $397m Purdue consumer health sale

A judge in the US has approved the sale of Purdue Pharma’s consumer health business Avrio, part of the bankruptcy proceedings related to the drugmaker’s proposed $10 billi

News

Ironwood wagers $1bn on VectivBio’s phase 3 readout

Gastrointestinal disease specialist Ironwood Pharma has agreed a $1 billion deal to buy VectivBio and its drug candidate for short bowel syndrome (SBS), betting on positiv

Novo Nordisk in talks to buy device maker Biocorp

Flurry of deals in biotech as M&A activity picks up

Lonza builds its ADC capacity with Synaffix takeover

Icahn pick displaces chair John Thompson on Illumina board

Bankruptcy court clears $397m Purdue consumer health sale

Ironwood wagers $1bn on VectivBio’s phase 3 readout

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

M&A

Editor's Picks